Phase II study of Fenretinide (N-[4-Hydroxyphenyl]retinamide) in advanced breast cancer and melanoma

Author:

Modiano Manuel R.,Dalton William S.,Lippman Scott M.,Joffe Leonard,Booth Ann R.,Meyskens Frank L.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Reference6 articles.

1. Lippman SM, Kassler JF, Meyskens FL: Retinoids as preventive and therapeutic anticancer agents. Cancer Treat Rep 71: 391–405 (Part I), 493–515 (Part II), 1987

2. Ratko TA, Detrisac CJ, Dinger NM, Thomas CF, Kelloff GJ, Moon RC: Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats. Cancer Res 49: 4472–4476, 1989

3. Dowlatshahi K, Mehta RG, Thomas CF, Dinger NM, Moon RC: Therapeutic effect of N-[4-hydroxyphenyl]retinamide on N-methyl-N-nitrosourea induced rat mammary cancer. Cancer Letters, in press, 1989

4. Costa A, Malone W, Perloff M, Buranelli F, Campa T, Dossena G, Magni A, Pizzichetta A, Andreoli C, Del Vecchio M, Formelli F, Barbieri A: Tolerability of the synthetic retinoid fenretinide (HPR). Eur J Cancer Clin Oncol 25: 805–808, 1989

5. Kaiser-Kupfer MI, Peck GL, Caruso RC, Jaffe MJ, DiGiovanna JJ, Gross EG: Abnormal retinal function associated with fenretinide, a synthetic retinoid. Arch Ophthalmol 104: 69–70, 1986

Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3